Skip to main content

Table 2 Meta-analysis of the CYP2E1 gene polymorphisms on breast cancer risk

From: Role of CYP2E1 polymorphisms in breast cancer: a systematic review and meta-analysis

Comparison

Population

No. of studies

Test of association

Mode

Heterogeneity

OR (95% CI)

P value

I2 (%)

P value

rs2031920 C>T

 T vs. C

Overall

3

0.91 (0.75–1.10)

0.317

F

0.0

0.380

 T/T vs. C/C

Overall

3

0.87 (0.27–2.87)

0.821

R

64.0

0.096

 C/T vs. C/C

Overall

3

0.94 (0.76–1.16)

0.549

F

0.0

0.414

 T/T + C/T vs. C/C

Overall

3

0.92 (0.75–1.13)

0.434

F

0.0

0.447

 T/T vs. C/T + C/C

Overall

3

0.87 (0.26–2.89)

0.825

R

64.3

0.094

CYP2E1*5 Rsa I/Pst I (c1/c2)

 c2 vs. c1

Overall

4

0.97 (0.80–1.17)

0.718

F

45.9

0.136

Asian

3

0.96 (0.80–1.16)

0.693

F

63.5

0.065

 c2/c2 vs. c1/c1

Overall

4

0.74 (0.42–1.30)

0.300

F

49.7

0.137

Asian

3

0.74 (0.82–1.30)

0.300

F

49.7

0.137

 c1/c2 vs. c1/c1

Overall

4

1.03 (0.81–1.29)

0.797

F

40.8

0.167

Asian

3

1.31 (0.74–2.34)

0.823

F

60.3

0.080

 c2/c2 + c1/c2 vs. c1/c1

Overall

4

1.00 (0.80–1.24)

0.994

F

44.4

0.145

Asian

3

1.00 (0.80–1.24)

0.965

F

62.6

0.069

 c2/c2 vs. c1/c2 + c1/c1

Overall

4

0.75 (0.43–1.30)

0.303

F

48.0

0.146

Asian

3

0.75 (0.43–1.30)

0.303

F

48.0

0.146

CYP2E1*6 Dra I (D/C)

 C vs. D

Overall

4

1.28 (1.05–1.55)

0.014

F

0.0

0.532

Caucasian

2

1.32 (1.06–1.64)

0.014

F

 C/C vs. D/D

Overall

4

1.47 (0.75–2.91)

0.266

F

0.0

0.667

Caucasian

2

1.66 (0.68–4.09)

0.268

F

 D/C vs. D/D

Overall

4

1.29 (1.04–1.61)

0.023

F

0.0

0.667

Caucasian

2

1.32 (1.04–1.68)

0.025

F

 C/C + D/C vs. D/D

Overall

4

1.25 (1.04–1.51)

0.019

F

0.0

0.724

Caucasian

2

1.26 (1.02–1.55)

0.032

F

18.0

0.269

 C/C vs. D/D + D/C

Overall

4

1.39 (0.71–2.72)

0.339

F

0.0

0.654

Caucasian

2

1.58 (0.64–3.89)

0.318

F

  1. F fixed-effects model, R random-effects model
  2. Italic values indicate significant difference (p < 0.05)